Citation Impact

Citing Papers

Signal transduction to hypoxia-inducible factor 1
2002 StandoutNobel
Prophylaxis in Liver Transplant Recipients Using A Fixed Dosing Schedule of Hepatitis B Immunoglobulin
1996
Hepatocellular carcinoma
2003 Standout
Beyond alcohol: Beverage consumption and cardiovascular mortality
1995
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Comparison of Surgical Outcomes for Hepatocellular Carcinoma in Patients With Hepatitis B Versus Hepatitis C: A Western Experience
2000
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
New Era of Liver Transplantation for Hepatitis B
2002
Hepatocellular carcinoma
2018 Standout
Clinical aspects of hepatitis B virus infection
1993
Liver resection of transplantation for hepatocellular carcinoma?
1997
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α
1997 StandoutNobel
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
1996
Screening for hepatocellular carcinoma
1999
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Hepatocellular carcinoma
2012 Standout
Hepatitis B virus infection
2009 Standout
Regulation of Cardiovascular Development and Physiology by Hypoxia‐Inducible Factor 1a
1999 StandoutNobel
Screening for hepatocellular carcinoma
2005
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis
2003
HIF-1 and mechanisms of hypoxia sensing
2001 StandoutNobel
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Vascular disorders of the liver # †
2008 Standout
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen
1993
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
IFN-γ and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation
2000
Management of Hepatocellular Carcinoma *
2005 Standout
Liver transplantation for chronic viral hepatitis
1995
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Structural and functional analysis of hypoxia-inducible factor 1
1997 StandoutNobel
Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver Transplantation
1999
Systemic amyloidosis
2015 Standout
Hypoxia-Inducible Factor 1
1998 StandoutNobel
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study
2001
Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-κB activation in rat hepatocytes
1999
Oxygen regulated gene expression: Erythropoietin as a model system
1997 StandoutNobel
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Treatment of Stage IVA Hepatocellular Carcinoma
2008
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Infection in Solid-Organ Transplant Recipients
2007 Standout
Paracetamol (acetaminophen) poisoning
1993
Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
2006
The Role of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) in Hypoxic Induction of Gene Expression
1996 StandoutNobel
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Hepatocellular Carcinoma
2011 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation?
2008
A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B
2001
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
Protein S-nitrosylation: purview and parameters
2005 Standout
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
2000 StandoutNobel
Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
1996
Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation
2009
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.
1995
Nitric oxide and the immune response
2001 Standout
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension
1996 StandoutNobel
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
N-acetylcysteine for sepsis and systemic inflammatory response in adults
2012
"Occult" hepatitis B virus as source of infection in liver transplant recipients
1994
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
1996 StandoutNobel
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Induction of Hypoxia-Inducible Factor-1, Erythropoietin, Vascular Endothelial Growth Factor, and Glucose Transporter-1 by Hypoxia: Evidence Against a Regulatory Role for Src Kinase
1997 StandoutNobel
Quantitation of hepatitis C virus RNA in liver transplant recipients
1994

Works of K C Tan being referenced

Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.
1995
Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation
1995
Orthotopic liver transplantation for hepatic-based metabolic disorders
1995
Liver transplantation in hepatocellular carcinoma
2000
Hepatitis B virus reinfection after orthotopic liver transplantation
1992
Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients
1994
Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation
1995
Orthotopic liver transplantation for hepatic-based metabolic disorders
1995
Liver transplantation after paracetamol overdose.
1991
NITRIC OXIDE GENERATION
1994
Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis
1995
Rankless by CCL
2026